Caplacizumab as rescue therapy in refractory TTP involving neurologic features

The role of caplacizumab in the routine treatment of immune thrombotic thrombocytopenic purpura (iTTP) remains to be established.

Source: Transfusion and Apheresis Science - February 10, 2023 Category: Hematology Authors: Minh-Ha Tran, Lisa X Lee, Yen Cao, Lan Vu, Zahra Pakbaz Tags: Case Report Source Type: research